Literature DB >> 31282942

Association of Nonmedical Prescription Opioid Use With Subsequent Heroin Use Initiation in Adolescents.

Lorraine I Kelley-Quon1,2,3, Junhan Cho2, David R Strong4, Richard A Miech5, Jessica L Barrington-Trimis2, Afton Kechter2, Adam M Leventhal2.   

Abstract

IMPORTANCE: There is concern that nonmedical prescription opioid use is associated with an increased risk of later heroin use initiation in adolescents, but to our knowledge, longitudinal data addressing this topic are lacking.
OBJECTIVE: To determine whether nonmedical prescription opioid use is associated with subsequent initiation of heroin use in adolescents. DESIGN, SETTING, AND PARTICIPANTS: This prospective longitudinal cohort study conducted in 10 high schools in Los Angeles, California, administered 8 semiannual surveys from 9th through 12th grade that assessed nonmedical prescription opioid use, heroin use, and other factors from October 2013 to July 2017. Students were baseline never users of heroin recruited through convenience sampling. Cox regression models tested nonmedical prescription opioid use statuses at survey waves 1 through 7 as a time-varying and time-lagged regressor and subsequent heroin use initiation across waves 2 to 8 as the outcome. EXPOSURES: Self-reported nonmedical prescription opioid use (past 30-day [current] use vs past 6-month [prior] use without past 30-day use vs no past 6-month use) at each wave from 1 to 7. MAIN OUTCOMES AND MEASURES: Self-reported heroin use initiation (yes/no) during waves 2 to 8.
RESULTS: Of 3298 participants, 1775 (53.9%) were adolescent girls, 1563 (48.3%) were Hispanic, 548 (17.0%) were Asian, 155 (4.8%) were African American, 529 (16.4%) were non-Hispanic white, and 220 (6.8%) were multiracial. Among baseline never users of heroin in ninth grade with valid data (3298 [97% of cohort enrollees]; mean [SD] age, 14.6 [0.4] years), the number of individuals with outcome data available at each follow-up ranged from 2987 (90.6%) to 3200 (97.0%). The mean per-wave prevalence of prior and current nonmedical prescription opioid use from waves 1 to 7 was 1.9% and 2.7%, respectively. Seventy students (2.1%) initiated heroin use during waves 2 to 8. Prior vs no (hazard ratio, 3.59; 95% CI, 2.14-6.01; P < .001) and current vs no (hazard ratio, 4.37; 95% CI, 2.80-6.81; P < .001) nonmedical prescription opioid use were positively associated with subsequent heroin use initiation. For no, prior, and current nonmedical prescription opioid use statuses at waves 1 to 7, the estimated cumulative probabilities of subsequent heroin use initiation by wave 8 (42-month follow-up) were 1.7%, 10.7%, and 13.1%, respectively. In covariate-adjusted models, associations were attenuated but remained statistically significant and current nonmedical prescription opioid use risk estimates were stronger than corresponding associations of nonopioid substance use with subsequent heroin use initiation. CONCLUSIONS AND RELEVANCE: Nonmedical prescription opioid use was prospectively associated with subsequent heroin use initiation during 4 years of adolescence among Los Angeles youth. Further research is needed to understand whether this association is causal.

Entities:  

Year:  2019        PMID: 31282942      PMCID: PMC6618794          DOI: 10.1001/jamapediatrics.2019.1750

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  19 in total

1.  Heroin and nonmedical prescription opioid use among high school students in urban school districts.

Authors:  Abenaa A Jones; Kristin E Schneider; Sherri-Chanelle Brighthaupt; Julie K Johnson; Sabriya L Linton; Renee M Johnson
Journal:  Drug Alcohol Depend       Date:  2019-10-25       Impact factor: 4.492

2.  Prescription Opioid Misuse and Sports-Related Concussion Among High School Students in the United States.

Authors:  See Wan Tham; Tonya M Palermo; Sara P D Chrisman; Cornelius B Groenewald
Journal:  J Head Trauma Rehabil       Date:  2021 Sep-Oct 01       Impact factor: 2.710

3.  Transitioning from pharmaceutical opioids: A discrete-time survival analysis of heroin initiation in suburban/exurban communities.

Authors:  T L Gaines; K D Wagner; M L Mittal; J M Bowles; E Copulsky; M Faul; R W Harding; P J Davidson
Journal:  Drug Alcohol Depend       Date:  2020-05-28       Impact factor: 4.492

4.  Preliminary Evaluation of a Prescription Opioid Misuse Prevention Program Among Rural Middle School Students.

Authors:  Reina Evans; Laura Widman; Hannah Javidi; Elizabeth Troutman Adams; Sam Cacace; Mitchell J Prinstein; Sarah L Desmarais
Journal:  J Community Health       Date:  2020-12

5.  Associations between insufficient sleep and prescription opioid misuse among high school students in the United States.

Authors:  Cornelius B Groenewald; Jennifer A Rabbitts; See Wan Tham; Emily F Law; Tonya M Palermo
Journal:  J Clin Sleep Med       Date:  2021-11-01       Impact factor: 4.062

6.  The prospective association between illicit drug use and nonprescription opioid use among vulnerable adolescents.

Authors:  James Russell Pike; Javad Salehi Fadardi; Alan W Stacy; Bin Xie
Journal:  Prev Med       Date:  2020-12-24       Impact factor: 4.018

7.  Distress tolerance and subsequent substance use throughout high school.

Authors:  Afton Kechter; Jessica L Barrington-Trimis; Junhan Cho; Jordan P Davis; Jimi Huh; David S Black; Adam M Leventhal
Journal:  Addict Behav       Date:  2021-05-08       Impact factor: 4.591

8.  Associations between adolescent sleep deficiency and prescription opioid misuse in adulthood.

Authors:  Cornelius B Groenewald; Emily F Law; Jennifer A Rabbitts; Tonya M Palermo
Journal:  Sleep       Date:  2021-03-12       Impact factor: 5.849

Review 9.  Substance use among adolescents and young adults with chronic kidney disease or kidney failure.

Authors:  Nianzhou Xiao; Hua Chai; Abiodun Omoloja
Journal:  Pediatr Nephrol       Date:  2021-03-09       Impact factor: 3.714

Review 10.  Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion.

Authors:  Lorraine I Kelley-Quon; Matthew G Kirkpatrick; Robert L Ricca; Robert Baird; Calista M Harbaugh; Ashley Brady; Paula Garrett; Hale Wills; Jonathan Argo; Karen A Diefenbach; Marion C W Henry; Juan E Sola; Elaa M Mahdi; Adam B Goldin; Shawn D St Peter; Cynthia D Downard; Kenneth S Azarow; Tracy Shields; Eugene Kim
Journal:  JAMA Surg       Date:  2021-01-01       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.